Is IV iron sucrose (intravenous iron sucrose) indicated for a male patient with End-Stage Renal Disease (ESRD), hemoglobin (Hgb) level of 12.8 g/dL, ferritin level of 160 ng/mL, and transferrin saturation (TSAT) of 28%?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Iron for Male ESRD Patient with Hgb 12.8, Ferritin 160, TSAT 28%

IV iron is NOT indicated for this patient based on current iron parameters and hemoglobin level. The patient's hemoglobin of 12.8 g/dL exceeds the target range of 11-12 g/dL for ESRD patients, and both ferritin (160 ng/mL) and TSAT (28%) are above the thresholds that trigger iron supplementation 1.

Guideline-Based Iron Thresholds for ESRD

The K/DOQI guidelines establish clear criteria for initiating IV iron in hemodialysis patients 1:

  • Iron supplementation is indicated when TSAT <20% and/or ferritin <100 ng/mL 1
  • This patient has TSAT of 28% (above the 20% threshold) and ferritin of 160 ng/mL (above the 100 ng/mL threshold) 1
  • IV iron should be withheld when TSAT >50% and/or ferritin >800 ng/mL 1

Hemoglobin Target Considerations

The patient's current hemoglobin level argues against additional iron therapy 1:

  • Target hemoglobin for ESRD patients is 11-12 g/dL 1
  • This patient's hemoglobin of 12.8 g/dL is already above target 1
  • Iron therapy is intended to achieve and maintain hemoglobin within the 11-12 g/dL range, not to exceed it 1

Optimal Iron Parameters for ESRD

More recent guidelines suggest higher iron targets may improve ESA responsiveness, but this patient already meets these thresholds 1:

  • For hemodialysis patients, maintaining TSAT >20% (ideally >30%) and ferritin >200 ng/mL can reduce ESA requirements 1
  • This patient's TSAT of 28% falls within the acceptable range 1
  • While ferritin of 160 ng/mL is below the 200 ng/mL target suggested for optimal ESA response, the hemoglobin is already above target, indicating adequate erythropoiesis 1

Monitoring Recommendations

Monitor iron parameters and hemoglobin every 3 months 1:

  • Measure TSAT and ferritin no less than every 3 months once stable 1
  • Reassess need for iron supplementation if TSAT falls below 20% or ferritin falls below 100 ng/mL 1
  • If hemoglobin drops below 11 g/dL and iron parameters decline, then initiate IV iron therapy 1

When to Initiate IV Iron in This Patient

IV iron would become indicated if any of the following develop 1:

  • TSAT drops below 20% 1
  • Ferritin falls below 100 ng/mL 1
  • Hemoglobin decreases below 11 g/dL despite adequate ESA dosing 1
  • Evidence of functional iron deficiency (high ferritin with low TSAT, though this patient shows the opposite pattern) 2

Dosing Algorithm If Iron Becomes Indicated

Should iron parameters fall below thresholds in the future, the recommended approach is 1:

  • Administer 100-125 mg IV iron at each hemodialysis session for 8-10 consecutive doses 1
  • Alternative: 500-1,000 mg iron dextran as single infusion after 25 mg test dose 1
  • Maintenance: 25-125 mg IV weekly once TSAT >20% and ferritin >100 ng/mL are achieved 1

Important Caveats

Ferritin interpretation in ESRD requires caution 1, 2, 3:

  • Ferritin is an acute-phase reactant and may be elevated due to inflammation independent of iron stores 1, 2, 3
  • TSAT may be a more reliable marker of iron availability for erythropoiesis in dialysis patients 1
  • When TSAT and ferritin values diverge (high ferritin with low TSAT), this typically indicates functional iron deficiency 2
  • This patient shows concordant values (both adequate), supporting the decision to withhold iron 2

Avoid the common pitfall of administering iron based solely on ferritin levels without considering hemoglobin and TSAT 4. In this case, all three parameters indicate iron supplementation is unnecessary.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Monitoring iron status in end-stage renal disease patients on hemodialysis.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2007

Guideline

Iron Deficiency Anemia in CKD Stage 2

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Can an End-Stage Renal Disease (ESRD) patient with thalassemia and elevated Transferrin Saturation (TSAT) and ferritin levels receive Venofer (iron sucrose)?
What is the best management approach for a patient with diabetes and Chronic Kidney Disease (CKD), presenting with iron deficiency anemia?
What interventions are recommended for a 70-year-old female with iron deficiency anemia (IDA), mild chronic kidney disease (CKD), low ferritin, and impaired renal function, as indicated by an estimated glomerular filtration rate (eGFR) of 57?
What is the treatment for a 61-year-old male patient with End-Stage Renal Disease (ESRD), anemia, low iron level, normal Mean Corpuscular Volume (MCV), and high ferritin level?
Should a patient with End-Stage Renal Disease (ESRD) anemia, Transferrin Saturation (Tsat) of 28% and elevated ferritin level of 800 ng/mL receive Erythropoietin (Epo)?
How to manage restless legs syndrome (RLS) in a patient with End-Stage Renal Disease (ESRD) and low magnesium levels?
When is mold urine testing indicated, particularly in patients with a history of mold exposure, compromised immune systems, or symptoms of respiratory illness, allergic reactions, or neurological problems?
Is whole egg nutrition superior to egg whites for a healthy individual with normal cholesterol levels and no history of heart disease?
What is the recommended treatment for a patient with confirmed Helicobacter pylori (H. pylori) infection and a history of dyspepsia or peptic ulcer disease?
What is the recommended pain management strategy for a post-thyroidectomy obese male patient?
What is the recommended management approach for a patient with low back pain, a positive Straight Leg Raise (SLR) test, and imaging findings consistent with mild to moderate lumbar spondylosis and multilevel lower lumbar degenerative disc disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.